Montrusco Bolton Investments Inc. Has $86.32 Million Stock Position in Zoetis Inc. (NYSE:ZTS)

Montrusco Bolton Investments Inc. lowered its position in shares of Zoetis Inc. (NYSE:ZTS) by 27.5% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 455,954 shares of the company’s stock after selling 173,314 shares during the quarter. Zoetis accounts for 0.9% of Montrusco Bolton Investments Inc.’s holdings, making the stock its 25th biggest position. Montrusco Bolton Investments Inc.’s holdings in Zoetis were worth $86,319,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Nwam LLC boosted its position in Zoetis by 4.1% during the 3rd quarter. Nwam LLC now owns 4,908 shares of the company’s stock worth $959,000 after acquiring an additional 193 shares during the last quarter. GM Advisory Group LLC boosted its position in Zoetis by 35.7% during the 3rd quarter. GM Advisory Group LLC now owns 1,899 shares of the company’s stock worth $371,000 after acquiring an additional 500 shares during the last quarter. Allen Capital Group LLC boosted its position in Zoetis by 23.4% during the 3rd quarter. Allen Capital Group LLC now owns 2,466 shares of the company’s stock worth $482,000 after acquiring an additional 467 shares during the last quarter. Biltmore Family Office LLC boosted its position in Zoetis by 5.0% during the 3rd quarter. Biltmore Family Office LLC now owns 1,771 shares of the company’s stock worth $346,000 after acquiring an additional 85 shares during the last quarter. Finally, First County Bank CT acquired a new position in Zoetis during the 3rd quarter worth approximately $318,000. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently commented on ZTS. JPMorgan Chase & Co. increased their price objective on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Stifel Nicolaus increased their price objective on Zoetis from $200.00 to $210.00 and gave the company a “buy” rating in a report on Wednesday, September 18th. Piper Sandler increased their price objective on Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a report on Wednesday, August 14th. Argus raised Zoetis to a “strong-buy” rating in a report on Friday, August 9th. Finally, BTIG Research increased their price objective on Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a report on Monday, August 12th. Ten research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $221.44.

Zoetis Trading Up 0.2 %

Shares of Zoetis stock opened at $176.98 on Friday. The business has a fifty day simple moving average of $185.62 and a two-hundred day simple moving average of $180.53. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $201.92. The company has a market capitalization of $79.85 billion, a price-to-earnings ratio of 33.27, a P/E/G ratio of 2.71 and a beta of 0.90. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.69 and a quick ratio of 2.27.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.12. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. During the same quarter last year, the business earned $1.36 EPS. The company’s quarterly revenue was up 11.6% compared to the same quarter last year. Research analysts forecast that Zoetis Inc. will post 5.9 EPS for the current year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be given a $0.432 dividend. This represents a $1.73 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date is Thursday, October 31st. Zoetis’s payout ratio is currently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.